Introduction

Pre-operative assessment in oral and maxillofacial surgery represents a critical quality assurance mechanism preventing surgical complications through identification and optimization of modifiable risk factors before procedure initiation. Comprehensive pre-operative evaluation includes detailed medical history documentation, review of current medications and potential drug interactions, assessment of anticoagulation status and perioperative management strategies, confirmation of appropriate imaging acquisition, acquisition of informed consent, and coordination with medical consultants for patients with significant comorbidities. This systematic approach reduces perioperative complications including excessive bleeding, infection, myocardial infarction, stroke, and adverse medication interactions that substantially increase morbidity. This article provides evidence-based pre-operative assessment protocols for practitioners managing surgical cases in office and hospital settings.

Medical History and Risk Assessment

Comprehensive medical history documentation forms the foundation of pre-operative assessment, requiring practitioners to obtain complete information regarding past medical and surgical history, current medications and supplements, drug allergies, prior anesthetic complications, and family history of anesthetic complications (particularly malignant hyperthermia). History should specifically address major organ system function: cardiac history (prior myocardial infarction, heart failure, arrhythmias, valvular disease), pulmonary history (asthma, COPD, sleep apnea, prior intubation difficulty), hepatic history (cirrhosis, hepatitis, alcohol use), renal history (chronic kidney disease, dialysis), endocrine history (diabetes, thyroid disease, adrenal insufficiency), and hematologic history (bleeding disorders, thrombosis history).

Risk stratification systems including the American Society of Anesthesiologists (ASA) classification help practitioners categorize patients by perioperative risk. ASA I patients (no medical comorbidities) represent minimal risk; ASA II patients (mild-moderate comorbidities) represent low risk; ASA III patients (severe comorbidities) represent moderate risk; ASA IV patients (severe life-threatening comorbidities) represent high risk; and ASA V patients (moribund) represent extreme risk. Practitioners should assign appropriate ASA classifications to all surgical patients, as such classification guides perioperative decision-making and complication risk understanding.

Detailed historical questioning should address symptom severity (chest pain, dyspnea, angina frequency and triggers), exercise tolerance, prior surgical complications, current medication compliance, and functional status. Patients unable to climb a flight of stairs or walk two blocks without dyspnea represent substantially elevated risk for perioperative cardiac complications. Documentation of recent hospitalizations, emergency department visits, or acute illness episodes provides additional context regarding baseline stability and perioperative risk.

Medication Review and Drug Interaction Assessment

Complete medication documentation including prescription medications, over-the-counter drugs, herbal supplements, and vitamins proves essential for identifying potential drug interactions with anesthetic agents and ensuring appropriate perioperative management of chronic medications. Special attention should address anticoagulants, antiplatelet agents, diabetes medications, antihypertensives, cardiac medications, and psychiatric medications, as these categories warrant specific perioperative management protocols.

Anticoagulation status represents perhaps the most critical pre-operative consideration, with patients on warfarin, direct oral anticoagulants (DOACs), or antiplatelet agents at substantially elevated bleeding risk. The need for perioperative anticoagulation cessation versus continuation depends on procedure bleeding risk, patient thrombotic risk, and specific anticoagulant type. Practitioners should consult with prescribing cardiologists regarding optimal anticoagulation management before surgical procedures, documenting such consultation in patient records.

Herbal supplements warrant particular attention, as many patients fail to disclose such products. St. John's Wort induces cytochrome P450 enzymes, reducing anesthetic drug efficacy; ginseng may increase bleeding risk; and kava potentiates sedation. Patients should receive explicit instruction regarding herbal supplement cessation 1-2 weeks before surgery.

Diabetes medications require specific perioperative management: insulin-dependent diabetics typically require reduced insulin dosing the morning of surgery (documented perioperative hyperglycemia increases infection risk, yet hypoglycemia during procedure presents acute danger); non-insulin diabetes medications are typically held the morning of procedure, with resumption only after adequate oral intake post-operatively. Detailed discussion with the patient's internist or endocrinologist clarifies optimal perioperative diabetes management.

Anticoagulation Management and Bleeding Risk Assessment

Perioperative anticoagulation management represents one of the most complex and consequential pre-operative decisions, with inappropriate management increasing either bleeding risk (if anticoagulation continued) or thrombotic risk (if anticoagulation abruptly discontinued). General principles dictate risk stratification based on bleeding risk (minor vs moderate vs major bleeding complications potential) and thrombotic risk (low vs moderate vs high thrombotic risk).

Patients on warfarin require assessment of indication (atrial fibrillation, mechanical heart valve, hypercoagulable states) and baseline international normalized ratio (INR) values. For minor bleeding procedures in low-thrombotic-risk patients, warfarin continuation targeting INR 2-3 is generally safe. For major procedures or high-thrombotic-risk patients, consultation with prescribing cardiologist regarding warfarin continuation, dose reduction, or bridging anticoagulation (intravenous unfractionated heparin during warfarin washout period) becomes necessary.

Direct oral anticoagulants (apixaban, rivaroxaban, dabigatran, edoxaban) require distinct perioperative management: typically held 24 hours before minor procedures and 48 hours before major procedures. Renal function substantially affects perioperative management, as reduced renal clearance extends drug half-lives and anticoagulant effects. Patients with significant renal impairment warrant extended anticoagulant cessation periods and consultation with anticoagulation specialists.

Aspirin and other antiplatelet agents typically are continued perioperatively, as their discontinuation increases thrombotic risk more substantially than continued administration increases bleeding risk. However, dual antiplatelet therapy (aspirin plus clopidogrel) warrants consultation with prescribing cardiologists regarding perioperative management, as some clinical scenarios warrant temporary discontinuation despite increased thrombotic risk.

Prophylactic Antibiotic Administration Guidelines

Surgical site infection prevention through appropriate prophylactic antibiotic administration represents one of the most effective perioperative risk reduction strategies. Current guidelines recommend prophylactic antibiotics for all surgical procedures extending beyond 30 minutes, procedures involving prosthetic material implantation, or patients with significant risk factors for infection (immunosuppression, prior surgical site infections, obesity, advanced age, diabetes, renal impairment).

For routine dentoalveolar surgery in healthy patients, amoxicillin 2 g orally 1 hour before procedure or cephalexin 2 g orally 1 hour before procedure provides adequate prophylaxis. For penicillin-allergic patients, clindamycin 600 mg orally 1 hour before procedure or azithromycin 500 mg orally 1 hour before procedure represents appropriate alternatives. For patients with high surgical site infection risk (immunosuppressed, diabetic, renal impairment, extensive surgical procedures), consultation with medical practitioners regarding appropriate prophylactic regimen proves prudent.

Extended prophylaxis beyond single pre-operative dose is rarely indicated in outpatient oral surgical procedures, though patients receiving intravenous conscious sedation or general anesthesia may warrant additional dosing based on anesthetic type and procedure duration. Practitioners should establish written antibiotic prophylaxis protocols for common surgical scenarios, ensuring consistent implementation.

Pre-Operative Imaging Requirements and Documentation

Appropriate diagnostic imaging before oral surgery optimizes surgical planning and reduces intraoperative surprises. Routine dentoalveolar surgery (simple extractions, straightforward implant placement) typically requires periapical or panoramic radiographs confirming tooth anatomy and bone structure. More complex procedures (orthognathic surgery, extensive implant cases, pathology management) warrant advanced imaging including cone beam computed tomography (CBCT) or conventional CT providing three-dimensional visualization facilitating surgical planning.

CBCT imaging allows precise assessment of bone volume and anatomy, identification of anatomic variations (inferior alveolar nerve canal, maxillary sinus location), and detection of pathology (cysts, tumors) affecting surgical approach. Such imaging should be acquired before definitive surgical planning, avoiding last-minute imaging delays. For implant cases, CBCT-based surgical planning and computer-guided implant placement substantially reduce nerve injury risk and optimize implant positioning.

Practitioners should establish imaging protocols specifying which diagnostic modalities are required for various surgical procedures, ensuring imaging is obtained before pre-operative appointment rather than leading to last-minute appointment delays. All imaging should be reviewed in detail before final surgical planning, with specific measurements or observations documented to guide surgical execution.

Informed consent represents a legal and ethical requirement for all surgical procedures, involving discussion of procedure indication, description of planned procedure, alternatives to proposed surgery, benefits of procedure, potential risks and complications, and any specific risks particularly relevant to individual patients. Documenting informed consent through written consent forms incorporating patient signature and dated practitioner signature provides essential medicolegal protection.

Informed consent discussions should address realistic complication risks rather than minimizing or exaggerating potential adverse effects. For dentoalveolar surgery, relevant risks include bleeding requiring additional hemostasis measures or post-operative hemorrhage control, swelling (typically 48-72 hours post-operative, occasionally extending 7-14 days), bruising (typically 10-14 days resolution), jaw stiffness (trismus, 3-10 days typically), infection (0.5-2% incidence depending on procedure type and patient risk factors), and procedure-specific risks (nerve injury with inferior alveolar or lingual nerve manipulation, sinus perforation with maxillary extractions, temporary sensory changes).

More extensive procedures warrant more detailed consent discussions addressing specific anatomic structures at risk, likelihood of sensory changes, possibility of staged procedures, and realistic recovery timelines. Practitioners should document in written consent forms that discussion occurred, allowing verification of adequate consent documentation if subsequent complications develop.

Pre-Operative Fasting Guidelines and NPO Status

Appropriate pre-operative fasting requirements reduce aspiration risk without excessive fasting-induced complications. American Society of Anesthesiologists guidelines recommend fasting intervals varying based on oral intake type: 2 hours fasting after clear liquid, 4 hours fasting after light meal, 6-8 hours fasting after fatty meal. Practitioners administering only local anesthesia to cooperative patients can typically proceed with minimal fasting restrictions, though some practitioners request light breakfast avoidance for local anesthesia cases to reduce nausea risk.

For procedures involving intravenous conscious sedation or general anesthesia, standard NPO (nothing by mouth) guidelines should be observed: no food for 6-8 hours, no clear liquids for 2 hours before procedure time. Patients should receive explicit written NPO instructions with specific time cutoffs, as violation of NPO status may necessitate procedure cancellation or delay to allow adequate gastric emptying.

Medications requiring continued perioperative administration (cardiac medications, seizure medications, respiratory medications) may be taken with minimal water despite NPO status. Patients taking antihypertensive medications should be counseled regarding continuation versus discontinuation morning-of-surgery; generally, antihypertensives are continued with minimal water, whereas medications with active titration (betablockers, calcium channel blockers) are often continued to prevent rebound hypertension perioperatively.

Pre-operative Vital Sign Assessment and Laboratory Testing

Baseline vital sign measurement (blood pressure, heart rate, temperature, respiratory rate) provides reference values for comparison with intraoperative values and identifies acute unstable conditions potentially necessitating procedure postponement. Significantly elevated blood pressure (systolic >180 mmHg, diastolic >110 mmHg) warrants consideration of procedure postponement and medical consultation regarding acute hypertension management.

Laboratory testing requirements vary based on patient age, ASA classification, and comorbidities. Younger, healthier ASA I or II patients typically require no laboratory testing for routine surgical procedures. Older patients (>60 years), ASA III+ patients, and those with specific medical conditions warrant pre-operative laboratory evaluation: complete blood count (CBC) assessing baseline hemoglobin and platelet count; comprehensive metabolic panel (CMP) assessing renal function, electrolytes, and glucose; and coagulation studies (PT/INR, PTT) if anticoagulation or bleeding disorder history exists.

Practitioners should establish pre-operative testing protocols based on patient characteristics, avoiding unnecessary testing (which delays procedures and increases costs) while ensuring adequate assessment of at-risk patients. Results should be reviewed before procedures, with abnormalities addressed through consultation with medical practitioners before surgical procedures.

Coordination with Medical Specialists and Anesthesia Consultation

Patients with significant medical complexity or specific surgical requirements may warrant consultation with medical specialists, cardiologists, pulmonologists, or anesthesia providers before surgical procedures. Patients with cardiac disease requiring surgical procedures warrant pre-operative cardiology clearance addressing perioperative cardiac risk and optimal medication management. Similarly, patients with significant pulmonary disease warrant pulmonary assessment, and those with renal impairment warrant nephrology input regarding medication adjustments and perioperative management.

Anesthesia consultation becomes necessary for procedures involving intravenous conscious sedation or general anesthesia, or for patients with significant medical comorbidities where anesthesia-specific expertise enhances perioperative safety. Anesthesia consultation should occur minimum 24 hours before procedures, allowing time for anesthetic planning and potential additional pre-operative optimization if necessary.

Documentation of specialist communications, recommendations, and agreed-upon perioperative management plans proves essential for coordinating multidisciplinary care and ensuring consistent management across providers.

Pre-operative Checklist and Verification Protocols

Implementing standardized pre-operative checklists reduces perioperative complications through systematic verification that all preparatory steps have been completed. Elements should include: verified surgical site and procedure indication, confirmation of informed consent documentation, review of allergies and adverse reactions, verification of imaging acquisition and review, confirmation of medication adjustments, assessment of anticoagulation status and management plan, completion of prophylactic antibiotic administration, NPO status verification for sedated procedures, vital sign measurement, and identification of any acute unstable conditions.

Checklists should be reviewed by entire surgical team immediately before procedures, with explicit verbal confirmation of critical elements (site marking, patient identity, procedure planned). Such "time-out" procedures reduce wrong-site surgery and wrong-procedure incidents substantially.

Electronic or paper-based tracking systems documenting completion of pre-operative steps provide accountability and allow identification of systematic gaps in pre-operative preparation, allowing protocol refinement. Practices should review pre-operative checklists periodically to identify opportunities for improvement and ensure checklist utility rather than allowing checklists to become rote, unthinking exercises.